Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
First Trust Nasdaq Oil & Gas ETF
FTXN
$159M
| $13.3M | ﹤0.01% |
476,758
-30,107
| -6% | -$841K |
|
3327
ADC Therapeutics
ADCT
$141M
| $13.3M | ﹤0.01% |
3,769,743
+100,676
| +3% | +$409K |
|
|
PMT
3328
PennyMac Mortgage Investment
PMT
$854M
| $13.3M | ﹤0.01% |
1,060,012
+42,921
| +4% | +$535K |
|
|
NIE
3329
Virtus Equity & Convertible Income Fund
NIE
$714M
| $13.3M | ﹤0.01% |
533,775
-3,740
| -0.7% | -$94.7K |
|
3330
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.15B
| $13.3M | ﹤0.01% |
548,762
-7,965
| -1% | -$193K |
|
3331
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.37B
| $13.3M | ﹤0.01% |
206,318
-37,080
| -15% | -$2.51M |
|
3332
Weis Markets
WMK
$1.9B
| $13.2M | ﹤0.01% |
206,723
-27,068
| -12% | -$1.81M |
|
|
MMT
3333
Aberdeen Multi-Market Income Fund
MMT
$238M
| $13.2M | ﹤0.01% |
2,845,731
-34,043
| -1% | -$160K |
|
|
KYIV
3334
Kyivstar Group
KYIV
$3.13B
| $13.2M | ﹤0.01% |
1,019,404
+916,926
| +895% | +$12.1M |
|
3335
Xenon Pharmaceuticals
XENE
$6.28B
| $13.2M | ﹤0.01% |
294,332
-72,240
| -20% | -$3.03M |
|
3336
Trevi Therapeutics
TRVI
$2.62B
| $13.1M | ﹤0.01% |
1,050,296
-3,251,430
| -76% | -$37.6M |
|
3337
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
| $13.1M | ﹤0.01% |
236,007
+5,612
| +2% | +$307K |
|
3338
Energy Recovery
ERII
$433M
| $13.1M | ﹤0.01% |
973,294
+42,435
| +5% | +$643K |
|
|
IGD
3339
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$510M
| $13.1M | ﹤0.01% |
2,294,112
-294,663
| -11% | -$1.71M |
|
3340
iRadimed
IRMD
$1.21B
| $13.1M | ﹤0.01% |
134,731
+7,529
| +6% | +$646K |
|
|
PML
3341
PIMCO Municipal Income Fund II
PML
$487M
| $13.1M | ﹤0.01% |
1,736,960
-252,512
| -13% | -$1.96M |
|
|
EH
3342
EHang Holdings
EH
$397M
| $13.1M | ﹤0.01% |
993,583
+689,436
| +227% | +$10.9M |
|
3343
Spectrum Brands
SPB
$2.08B
| $13.1M | ﹤0.01% |
221,381
-29,385
| -12% | -$1.65M |
|
3344
Franklin Income Focus ETF
INCM
$1.7B
| $13M | ﹤0.01% |
464,961
+356,079
| +327% | +$9.93M |
|
3345
Invesco BulletShares 2027 Municipal Bond ETF
BSMR
$344M
| $13M | ﹤0.01% |
550,284
+3,749
| +0.7% | +$88.7K |
|
3346
WisdomTree International SmallCap Dividend Fund
DLS
$1.05B
| $13M | ﹤0.01% |
160,714
-19,979
| -11% | -$1.58M |
|
|
ESPR
3347
DELISTED
Esperion Therapeutics
ESPR
| $13M | ﹤0.01% |
3,514,227
-541,399
| -13% | -$1.75M |
|
3348
Unitil
UTL
$1.01B
| $13M | ﹤0.01% |
268,046
+82,266
| +44% | +$4M |
|
3349
Cambria Global Value ETF
GVAL
$572M
| $13M | ﹤0.01% |
412,217
+40,810
| +11% | +$1.24M |
|
3350
Ivanhoe Electric
IE
$1.44B
| $13M | ﹤0.01% |
811,335
-319,397
| -28% | -$4.57M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.